EP Edge Journal Watch | Episode 1, November 2025: Potassium and VT, GDMT Withdrawal & AF Risk Uncovered
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
-
Narrated by:
-
By:
About this listen
In this inaugural episode, Dr. Niraj Sharma breaks down three pivotal studies that could shift daily EP practice:
- How high-normal potassium targeting can reduce VT burden (POT-CAST trial).
- When GDMT withdrawal may be safe after recovery from tachycardia-induced cardiomyopathy.
- Why adverse pregnancy outcomes may predict long-term AF risk.
Get the signal — not the noise — with expert analysis, clinical context, and practical takeaways for the EP lab.
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.